Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 6005

1.

Exceeding Metal Capacity in Sandwich Complexes: Ligand-unsupported Docking of Extra Metal Moieties at Edges of a Metal Sheet Sandwich Complex.

Ishikawa T, Kawamura A, Sugawa T, Moridaira R, Yamamoto K, Murahashi T.

Angew Chem Int Ed Engl. 2019 Aug 15. doi: 10.1002/anie.201908850. [Epub ahead of print]

PMID:
31415115
2.

Postovulatory ageing modifies sperm-induced Ca2+ oscillations in mouse oocytes through a conditions-dependent, multi-pathway mechanism.

Szpila M, Walewska A, Sabat-Pośpiech D, Strączyńska P, Ishikawa T, Milewski R, Szczepańska K, Ajduk A.

Sci Rep. 2019 Aug 14;9(1):11859. doi: 10.1038/s41598-019-48281-3.

3.

Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study.

Naito Y, Kai Y, Ishikawa T, Fujita T, Uehara K, Doihara H, Tokunaga S, Shimokawa M, Ito Y, Saeki T.

Breast Cancer. 2019 Aug 12. doi: 10.1007/s12282-019-01001-1. [Epub ahead of print]

PMID:
31407150
4.

Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.

Nakagawa M, Nakatani F, Matsunaga H, Seki T, Endo M, Ogawara Y, Machida Y, Katsumoto T, Yamagata K, Hattori A, Fujita S, Aikawa Y, Ishikawa T, Soga T, Kawai A, Chuman H, Yokoyama N, Fukushima S, Yahiro K, Kimura A, Shimada E, Hirose T, Fujiwara T, Setsu N, Matsumoto Y, Iwamoto Y, Nakashima Y, Kitabayashi I.

Oncogene. 2019 Aug 12. doi: 10.1038/s41388-019-0929-9. [Epub ahead of print]

PMID:
31406254
5.

Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer.

Sakaguchi K, Ono H, Nakatsukasa K, Ishikawa T, Hasegawa Y, Takahashi M, Niikura N, Koizumi K, Sakurai T, Shigematsu H, Takahashi S, Taira S, Suzuki M, Narui K, Miura D, Yamada K, Yoshimura M, Shioya H, Konishi E, Isao Y, Imai K, Fujikawa K, Taguchi T; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.

Medicine (Baltimore). 2019 Aug;98(32):e16770. doi: 10.1097/MD.0000000000016770.

6.

Effect of Anisotropic Hybridization in YbAlB_{4} Probed by Linear Dichroism in Core-Level Hard X-Ray Photoemission Spectroscopy.

Kuga K, Kanai Y, Fujiwara H, Yamagami K, Hamamoto S, Aoyama Y, Sekiyama A, Higashiya A, Kadono T, Imada S, Yamasaki A, Tanaka A, Tamasaku K, Yabashi M, Ishikawa T, Nakatsuji S, Kiss T.

Phys Rev Lett. 2019 Jul 19;123(3):036404. doi: 10.1103/PhysRevLett.123.036404.

PMID:
31386467
7.

27-Hydroxycholesterol Promotes Adiposity and Mimics Adipogenic Diet-induced Inflammatory Signaling.

Asghari A, Ishikawa T, Hiramitsu S, Lee WR, Umetani J, Bui L, Korach KS, Umetani M.

Endocrinology. 2019 Aug 6. pii: en.2019-00349. doi: 10.1210/en.2019-00349. [Epub ahead of print]

PMID:
31386147
8.
9.

Peel-off resection of the pituitary gland for functional pituitary adenomas: pathological significance and impact on pituitary function.

Nagata Y, Takeuchi K, Yamamoto T, Ishikawa T, Kawabata T, Shimoyama Y, Inoshita N, Wakabayashi T.

Pituitary. 2019 Aug 3. doi: 10.1007/s11102-019-00980-w. [Epub ahead of print]

PMID:
31377966
10.

Prediction of 1,4-dioxane decomposition during VUV treatment by model simulation taking into account effects of coexisting inorganic ions.

Matsushita T, Sugita W, Ishikawa T, Shi G, Nishizawa S, Matsui Y, Shirasaki N.

Water Res. 2019 Jul 26;164:114918. doi: 10.1016/j.watres.2019.114918. [Epub ahead of print]

PMID:
31377528
11.

Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 Treatment.

Hayashi M, Nakazawa K, Hasegawa Y, Horiguchi J, Miura D, Ishikawa T, Takao S, Kim SJ, Yamagami K, Miyashita M, Konishi M, Shigeoka Y, Suzuki M, Taguchi T, Kubota T, Tanino H, Yamada K, Narui K, Kimura K, Akazawa K, Kohno N; JONIE STUDY GROUP.

Anticancer Res. 2019 Aug;39(8):4305-4314. doi: 10.21873/anticanres.13596.

PMID:
31366522
12.

Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.

Shimizu T, Kamata M, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Ohnishi T, Tada Y.

J Dermatol Sci. 2019 Jul 23. pii: S0923-1811(19)30213-0. doi: 10.1016/j.jdermsci.2019.07.006. [Epub ahead of print]

PMID:
31362906
13.

Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.

Kawabata H, Usuki K, Shindo-Ueda M, Kanda J, Tohyama K, Matsuda A, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Chiba S, Ishikawa T, Arima N, Nohgawa M, Miyazaki Y, Kurokawa M, Arai S, Mitani K, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Int J Hematol. 2019 Jul 29. doi: 10.1007/s12185-019-02710-1. [Epub ahead of print]

PMID:
31359362
14.

Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.

Hatada Y, Hashimoto M, Shiraishi S, Ishikawa T, Fukuhara R, Yuki S, Tanaka H, Miyagawa Y, Kitajima M, Uetani H, Tsunoda N, Koyama A, Ikeda M.

J Alzheimers Dis. 2019 Jul 23. doi: 10.3233/JAD-190272. [Epub ahead of print]

PMID:
31356206
15.

IRR is involved in glucose-induced endocytosis after insulin secretion.

Yamaoka M, Terabayashi T, Nishioka T, Kaibuchi K, Ishikawa T, Ishizaki T, Kimura T.

J Pharmacol Sci. 2019 Jul 5. pii: S1347-8613(19)35677-4. doi: 10.1016/j.jphs.2019.07.002. [Epub ahead of print]

16.

Spontaneous regression of quiescent gestational trophoblastic disease after pregnancy: a case report.

Okada Y, Miyamoto S, Mimura T, Ishikawa T, Sekizawa A, Matsumoto K.

BMC Womens Health. 2019 Jul 23;19(1):101. doi: 10.1186/s12905-019-0794-2.

17.

Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.

Iida S, Watanabe T, Matsumoto M, Suzuki K, Sunami K, Ishida T, Ando K, Chou T, Ozaki S, Taniwaki M, Uike N, Shibayama H, Hatake K, Izutsu K, Ishikawa T, Shumiya Y, Tobinai K.

Cancer Sci. 2019 Jul 23. doi: 10.1111/cas.14139. [Epub ahead of print]

18.

Generation of magnifying endoscopic images of gastric neoplasms based on an all-in-focus algorithm.

Matsui K, Funasaka K, Miyahara R, Furukawa K, Matsushita M, Yamamura T, Ishikawa T, Ohno E, Nakamura M, Kawashima H, Watanabe O, Ohara K, Hirooka Y, Goto H.

J Gastroenterol Hepatol. 2019 Jul 23. doi: 10.1111/jgh.14792. [Epub ahead of print]

PMID:
31334881
19.

Evaluation of screening for drug use using postmortem prolactin levels in serum and cerebrospinal fluid.

Tani N, Ikeda T, Aoki Y, Shida A, Oritani S, Ishikawa T.

Hum Exp Toxicol. 2019 Jul 18:960327119864139. doi: 10.1177/0960327119864139. [Epub ahead of print]

PMID:
31319705
20.

Usefulness of the Daily Life Performance Transfer Sheet in Care Management of People With Stroke.

Iokawa K, Hasegawa K, Ishikawa T.

Am J Occup Ther. 2019 Jul/Aug;73(4):7304205080p1-7304205080p7. doi: 10.5014/ajot.2019.031468.

PMID:
31318672
21.

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Tanaka H, Tamai T, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Oncology. 2019 Jul 15:1-9. doi: 10.1159/000501281. [Epub ahead of print]

PMID:
31307035
22.

Linked color imaging identifies important risk factors associated with gastric cancer after successful Helicobacter pylori eradication.

Majima A, Dohi O, Takayama S, Hirose R, Inoue K, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Takagi T, Handa O, Konishi H, Naito Y, Itoh Y.

Gastrointest Endosc. 2019 Jul 9. pii: S0016-5107(19)32047-4. doi: 10.1016/j.gie.2019.06.043. [Epub ahead of print]

PMID:
31299258
23.

Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus.

Saito K, Kuwahara A, Ishikawa T, Morisaki N, Miyado M, Miyado K, Fukami M, Miyasaka N, Ishihara O, Irahara M, Saito H.

Hum Reprod. 2019 Jul 12. pii: dez079. doi: 10.1093/humrep/dez079. [Epub ahead of print]

PMID:
31299081
24.

Physcomitrella STEMIN transcription factor induces stem cell formation with epigenetic reprogramming.

Ishikawa M, Morishita M, Higuchi Y, Ichikawa S, Ishikawa T, Nishiyama T, Kabeya Y, Hiwatashi Y, Kurata T, Kubo M, Shigenobu S, Tamada Y, Sato Y, Hasebe M.

Nat Plants. 2019 Jul;5(7):681-690. doi: 10.1038/s41477-019-0464-2. Epub 2019 Jul 8.

PMID:
31285563
25.

Dual effect of reduced type I diacylglycerol kinase activity on insulin secretion from MIN6 β-cells.

Sawatani T, Kaneko YK, Ishikawa T.

J Pharmacol Sci. 2019 Jun;140(2):178-186. doi: 10.1016/j.jphs.2019.06.001. Epub 2019 Jun 15.

26.

A Short Peptide Derived from the ZorO Toxin Functions as an Effective Antimicrobial.

Otsuka Y, Ishikawa T, Takahashi C, Masuda M.

Toxins (Basel). 2019 Jul 4;11(7). pii: E392. doi: 10.3390/toxins11070392.

27.

[Long-Term Survival of a Patient with Small Cell Esophageal Carcinoma Who Underwent Multidisciplinary Therapy-ACase Report].

Ota T, Ishikawa T, Hotta Y, Okayama T, Shiozaki A, Fujiwara H, Kishimoto M, Konishi H, Naito Y, Itoh Y.

Gan To Kagaku Ryoho. 2019 Jun;46(6):1053-1056. Japanese.

PMID:
31273174
28.

Matrix-producing Carcinoma as an Aggressive Triple-negative Breast Cancer: Clinicopathological Features and Response to Neoadjuvant Chemotherapy.

Shimada K, Ishikawa T, Yamada A, Sugae S, Narui K, Shimizu D, Chishima T, Endo I.

Anticancer Res. 2019 Jul;39(7):3863-3869. doi: 10.21873/anticanres.13536.

PMID:
31262914
29.

External Radiation Dose, Obesity, and Risk of Childhood Thyroid Cancer after the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management Survey.

Ohira T, Ohtsuru A, Midorikawa S, Takahashi H, Yasumura S, Suzuki S, Matsuzuka T, Shimura H, Ishikawa T, Sakai A, Suzuki S, Yamashita S, Yokoya S, Tanigawa K, Ohto H, Kamiya K; Fukushima Health Management Survey group.

Epidemiology. 2019 Jun 25. doi: 10.1097/EDE.0000000000001058. [Epub ahead of print]

PMID:
31259849
30.

Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma.

Maruyama D, Nagai H, Fukuhara N, Kitano T, Ishikawa T, Nishikawa T.

J Clin Exp Hematop. 2019;59(2):98-100. doi: 10.3960/jslrt.19006. No abstract available.

31.

Full-field X-ray fluorescence microscope based on total-reflection advanced Kirkpatrick-Baez mirror optics.

Matsuyama S, Yamada J, Kohmura Y, Yabashi M, Ishikawa T, Yamauchi K.

Opt Express. 2019 Jun 24;27(13):18318-18328. doi: 10.1364/OE.27.018318.

PMID:
31252777
32.

Characterization of Microbiota in Endometrial Fluid and Vaginal Secretions in Infertile Women with Repeated Implantation Failure.

Kitaya K, Nagai Y, Arai W, Sakuraba Y, Ishikawa T.

Mediators Inflamm. 2019 May 21;2019:4893437. doi: 10.1155/2019/4893437. eCollection 2019.

33.

Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity.

Yoshioka N, Kuzuya T, Ito T, Ishizu Y, Honda T, Ishikawa T, Ishigami M, Fujishiro M.

Intern Med. 2019 Jun 27. doi: 10.2169/internalmedicine.2812-19. [Epub ahead of print]

34.

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study.

Takano N, Yamada S, Hirakawa A, Yokoyama Y, Kawashima H, Maeda O, Okada T, Ohno E, Yamaguchi J, Ishikawa T, Sonohara F, Suenaga M, Takami H, Hayashi M, Niwa Y, Hirooka Y, Ito Y, Naganawa S, Ando Y, Nagino M, Goto H, Fujii T, Kodera Y.

Nagoya J Med Sci. 2019 May;81(2):233-239. doi: 10.18999/nagjms.81.2.233.

35.

Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101.

Narui K, Ishikawa T, Shimizu D, Yamada A, Tanabe M, Sasaki T, Oba MS, Morita S, Nawata S, Kida K, Mogaki M, Doi T, Tsugawa K, Ogata H, Ota T, Kosaka Y, Sengoku N, Kuranami M, Niikura N, Saito Y, Suzuki Y, Suto A, Arioka H, Chishima T, Ichikawa Y, Endo I, Tokuda Y.

Breast. 2019 Jun 15;47:1-9. doi: 10.1016/j.breast.2019.06.003. [Epub ahead of print]

PMID:
31229857
36.

Ataxic phenotype with altered CaV3.1 channel property in a mouse model for spinocerebellar ataxia 42.

Hashiguchi S, Doi H, Kunii M, Nakamura Y, Shimuta M, Suzuki E, Koyano S, Okubo M, Kishida H, Shiina M, Ogata K, Hirashima F, Inoue Y, Kubota S, Hayashi N, Nakamura H, Takahashi K, Katsumoto A, Tada M, Tanaka K, Sasaoka T, Miyatake S, Miyake N, Saitsu H, Sato N, Ozaki K, Ohta K, Yokota T, Mizusawa H, Mitsui J, Ishiura H, Yoshimura J, Morishita S, Tsuji S, Takeuchi H, Ishikawa K, Matsumoto N, Ishikawa T, Tanaka F.

Neurobiol Dis. 2019 Oct;130:104516. doi: 10.1016/j.nbd.2019.104516. Epub 2019 Jun 20.

PMID:
31229688
37.

Evaluation of double heptamer-type sgRNA as a potential therapeutic agent against multiple myeloma.

Ishikawa T, Haino A, Ichiyanagi T, Seki M, Nashimoto M.

Blood Cells Mol Dis. 2019 Jun 12;79:102341. doi: 10.1016/j.bcmd.2019.102341. [Epub ahead of print]

PMID:
31226499
38.

Color information from linked color imaging is associated with invasion depth and vascular diameter in superficial esophageal squamous cell carcinoma.

Kobayashi K, Miyahara R, Funasaka K, Furukawa K, Sawada T, Maeda K, Yamamura T, Ishikawa T, Ohno E, Nakamura M, Kawashima H, Nakaguro M, Okumura Y, Hirooka Y, Fujishiro M.

Dig Endosc. 2019 Jun 20. doi: 10.1111/den.13469. [Epub ahead of print]

PMID:
31220372
39.

Increased hardness of the underlying pancreas correlates with the presence of intraductal papillary-mucinous neoplasm in a limited number of cases.

Koya T, Kawashima H, Ohno E, Ishikawa T, Ishigami M, Hashimoto S, Goto H, Hirooka Y.

J Med Ultrason (2001). 2019 Jun 19. doi: 10.1007/s10396-019-00956-0. [Epub ahead of print]

PMID:
31218473
40.

Sarcopenia impairs health-related quality of life in cirrhotic patients.

Ando Y, Ishigami M, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Fujishiro M.

Eur J Gastroenterol Hepatol. 2019 Jun 14. doi: 10.1097/MEG.0000000000001472. [Epub ahead of print]

PMID:
31206408
41.

Cost Effectiveness of Drive and Retrieve System in Hokkaido for Acute Ischemic Stroke Patient Treatment Using Geographic Information System.

Morii Y, Osanai T, Ishikawa T, Fujiwara K, Tanikawa T, Houkin K, Kobayashi E, Ogasawara K.

J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2292-2301. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.020. Epub 2019 Jun 12.

PMID:
31200963
42.

Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy.

Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.

PLoS One. 2019 Jun 13;14(6):e0218136. doi: 10.1371/journal.pone.0218136. eCollection 2019.

43.

Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Mild Diabetes Mellitus Following Treatment With Pioglitazone: Reports of a Randomised Trial From The Japan Working Group for the Assessment Whether Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study).

Asakura M, Kim J, Asanuma H, Nakama Y, Tsukahara K, Higashino Y, Ishikawa T, Koba S, Tsujimoto M, Himeno H, Maruyama Y, Ookusa T, Yoda S, Suzuki H, Okubo S, Shimizu M, Hashimoto Y, Satake K, Fujino S, Uzui H, Nagai Y, Kohno T, Mizuno S, Nakahama M, Kanaya H, Murohara T, Fukui K, Takase H, Ohte N, Shiono T, Fukunami M, Endo T, Sawada R, Fujii K, Takeuchi M, Ikeda S, Mizuno K, Uematsu M, Matsubara T, Yano S, Takahashi J, Ueda K, Kinoshita Y, Tamita K, Hayashi H, Hamasaki T, Kitakaze M; PPAR investigators.

EClinicalMedicine. 2018 Oct 22;4-5:10-24. doi: 10.1016/j.eclinm.2018.09.006. eCollection 2018 Oct-Nov.

44.

Port site recurrence and unusual diffuse subcutaneous metastases of unexpected early stage ovarian cancer after laparoscopic surgery: a case report.

Fusegi A, Oshima N, Nakasuji T, Ishikawa T, Wakana K, Yoshiki N, Miyasaka N.

J Rural Med. 2019 May;14(1):143-147. doi: 10.2185/jrm.3000. Epub 2019 May 30.

45.

Roles of YIGL sequence of Ebola virus VP40 on genome replication and particle production.

Urata S, Ishikawa T, Yasuda J.

J Gen Virol. 2019 Jul;100(7):1099-1111. doi: 10.1099/jgv.0.001286. Epub 2019 Jun 11.

PMID:
31184566
46.

Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.

Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Matsuda C, Nakamoto Y, Kotake M, Kurachi K, Egawa T, Yasumasa K, Murata K, Ikawa O, Shinji S, Murotani K, Matsui S, Teramukai S, Tomita N, Sugihara K; SACURA Study Group.

J Clin Oncol. 2019 Aug 1;37(22):1886-1894. doi: 10.1200/JCO.18.02059. Epub 2019 Jun 10.

PMID:
31180819
47.

How and When? Metacognition and Solution Timing Characterize an "Aha" Experience of Object Recognition in Hidden Figures.

Ishikawa T, Toshima M, Mogi K.

Front Psychol. 2019 May 22;10:1023. doi: 10.3389/fpsyg.2019.01023. eCollection 2019.

48.

A unidirectional porous beta-tricalcium phosphate material (Affinos®) for reconstruction of bony defects after excision of fibular bone for spinal surgery graft.

Noguchi H, Funayama T, Koda M, Iijima Y, Kumagai H, Ishikawa T, Aiba A, Abe T, Nagashima K, Miura K, Izawa S, Maki S, Furuya T, Yamazaki M.

J Clin Neurosci. 2019 Aug;66:71-76. doi: 10.1016/j.jocn.2019.05.021. Epub 2019 Jun 4.

PMID:
31174946
49.

Comparison of Motion Artifacts on CT Images Obtained in the Ultrafast Scan Mode and Conventional Scan Mode for Unconscious Patients in the Emergency Department.

Takayanagi T, Suzuki S, Katada Y, Ishikawa T, Fukui R, Yamamoto Y, Abe O.

AJR Am J Roentgenol. 2019 Jun 5:1-9. doi: 10.2214/AJR.19.21456. [Epub ahead of print]

PMID:
31166767
50.

Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet's disease.

Tsuchida N, Kirino Y, Soejima Y, Onodera M, Arai K, Tamura E, Ishikawa T, Kawai T, Uchiyama T, Nomura S, Kobayashi D, Taguri M, Mitsuhashi S, Mizuguchi T, Takata A, Miyake N, Nakajima H, Miyatake S, Matsumoto N.

Arthritis Res Ther. 2019 Jun 4;21(1):137. doi: 10.1186/s13075-019-1928-5.

Supplemental Content

Loading ...
Support Center